About aytu biopharma inc - AYTU
Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR, and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Denver, CO.
AYTU At a Glance
Aytu Biopharma, Inc.
7900 East Union Avenue
Denver, Colorado 80237
| Phone | 1-720-437-6580 | Revenue | 66.38M | |
| Industry | Pharmaceuticals: Major | Net Income | -13,562,000.00 | |
| Sector | Health Technology | Employees | 83 | |
| Fiscal Year-end | 06 / 2026 | |||
| View SEC Filings |
AYTU Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.206 |
| Price to Book Ratio | 1.032 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 0.717 |
| Enterprise Value to Sales | 0.085 |
| Total Debt to Enterprise Value | 4.042 |
AYTU Efficiency
| Revenue/Employee | 799,783.133 |
| Income Per Employee | -163,397.59 |
| Receivables Turnover | 2.131 |
| Total Asset Turnover | 0.546 |
AYTU Liquidity
| Current Ratio | 1.256 |
| Quick Ratio | 1.074 |
| Cash Ratio | 0.491 |
AYTU Profitability
| Gross Margin | 63.493 |
| Operating Margin | 3.822 |
| Pretax Margin | -20.706 |
| Net Margin | -20.43 |
| Return on Assets | -11.659 |
| Return on Equity | -60.76 |
| Return on Total Capital | -33.845 |
| Return on Invested Capital | -40.511 |
AYTU Capital Structure
| Total Debt to Total Equity | 120.937 |
| Total Debt to Total Capital | 54.738 |
| Total Debt to Total Assets | 18.434 |
| Long-Term Debt to Equity | 62.638 |
| Long-Term Debt to Total Capital | 28.351 |